Giuseppe Buono

1.4k total citations
29 papers, 681 citations indexed

About

Giuseppe Buono is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Giuseppe Buono has authored 29 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 16 papers in Cancer Research and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Giuseppe Buono's work include Breast Cancer Treatment Studies (13 papers), HER2/EGFR in Cancer Research (12 papers) and Advanced Breast Cancer Therapies (7 papers). Giuseppe Buono is often cited by papers focused on Breast Cancer Treatment Studies (13 papers), HER2/EGFR in Cancer Research (12 papers) and Advanced Breast Cancer Therapies (7 papers). Giuseppe Buono collaborates with scholars based in Italy, United Kingdom and United States. Giuseppe Buono's co-authors include Sabino De Placido, Lucia Del Mastro, Grazia Arpino, Mario Giuliano, Michelino De Laurentiis, Fabio Puglisi, Lorenzo Gerratana, Francesco Schettini, Debora Basile and Richard J. Twitchett and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Giuseppe Buono

28 papers receiving 674 citations

Peers

Giuseppe Buono

ONCOL

PRM

GENET

Chunxiao Li China

José Antonio López-Ruiz Spain

Shengli Yang China

Yuanyuan Hu China

Tsung‐Hao Liu Taiwan

Zhen Tao China

Izumi Sakamoto Japan

Roberta Marciano Italy

Jung‐Eun Lee South Korea

Christina Maria Lutz Denmark

Chunxiao Li China

Giuseppe Buono

159 ×0.4

ONCOL

387 ×1.3

98 ×0.5

PRM

378 ×2.1

48 ×0.6

GENET

Citations per year, relative to Giuseppe Buono Giuseppe Buono (= 1×) peers Chunxiao Li

Countries citing papers authored by Giuseppe Buono

Since Specialization

Citations

This map shows the geographic impact of Giuseppe Buono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Buono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Buono more than expected).

Fields of papers citing papers by Giuseppe Buono

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe Buono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Buono. The network helps show where Giuseppe Buono may publish in the future.

Co-authorship network of co-authors of Giuseppe Buono

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe Buono. A scholar is included among the top collaborators of Giuseppe Buono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe Buono. Giuseppe Buono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Buono, Giuseppe, Monica Capozzi, Roberta Caputo, et al.. (2024). CAR-T cell therapy for breast cancer: Current status and future perspective. Cancer Treatment Reviews. 133. 102868–102868. 7 indexed citations

Caputo, Roberta, Giuseppe Buono, Michela Piezzo, et al.. (2024). Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis. Frontiers in Oncology. 14. 1362641–1362641. 29 indexed citations

Munzone, Elisabetta, Alessandra Fabi, Giuseppe Buono, et al.. (2023). The PHASTER Study: Economic and Organizational Impact of Subcutaneous (SC) Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Treatment of HER2+ Breast Cancer Patients. Drugs & Therapy Perspectives. 39(12). 432–446.

Sirico, Marianna, Benedetta Conte, Milena Urbini, et al.. (2022). Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives. Critical Reviews in Oncology/Hematology. 181. 103900–103900. 14 indexed citations

Diana, Anna, Francesca Carlino, Giuseppe Buono, et al.. (2022). Prognostic Relevance of Progesterone Receptor Levels in Early Luminal-Like HER2 Negative Breast Cancer Subtypes: A Retrospective Analysis. Frontiers in Oncology. 12. 813462–813462. 5 indexed citations

Buono, Giuseppe, Grazia Arpino, Lucia Del Mastro, et al.. (2022). Extended adjuvant endocrine treatment for premenopausal women: A Delphi approach to guide clinical practice. Frontiers in Oncology. 12. 1032166–1032166. 4 indexed citations

Romano, Giorgio, Giuseppe Buono, Massimo Galia, et al.. (2022). Role of preoperative CT angiography with multimodality imaging reconstruction to perform laparoscopic Complete Mesocolic Excision (CME) and Central Vascular Ligation (CVL) in right-sided colon cancer: Is it really useful? A prospective clinical study. European Journal of Surgical Oncology. 49(1). 209–216. 9 indexed citations

Buono, Giuseppe, et al.. (2021). Breast Cancer Adjuvant Radiotherapy in BRCA1/2, TP53, ATM Genes Mutations: Are There Solved Issues?. Breast Cancer Targets and Therapy. Volume 13. 299–310. 12 indexed citations

Canfora, Federica, Elena Calabria, Renato Cuocolo, et al.. (2021). Burning Fog: Cognitive Impairment in Burning Mouth Syndrome. Frontiers in Aging Neuroscience. 13. 727417–727417. 25 indexed citations

10.

Prete, Salvatore Del, Liliana Montella, Grazia Arpino, et al.. (2020). Second line trastuzumab emtansine following horizontal dual blockade in a real-life setting. Oncotarget. 11(22). 2083–2091. 8 indexed citations

11.

Buono, Giuseppe, Lorenzo Gerratana, Michela Bulfoni, et al.. (2019). Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time?. Cancer Treatment Reviews. 73. 73–83. 87 indexed citations

12.

Placido, Sabino De, Mario Giuliano, Francesco Schettini, et al.. (2018). Human epidermal growth factor receptor 2 dual blockade with trastuzumab and pertuzumab in real life: Italian clinical practice versus the CLEOPATRA trial results. The Breast. 38. 86–91. 20 indexed citations

13.

Gerratana, Lorenzo, Debora Basile, Giuseppe Buono, et al.. (2018). Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype. Cancer Treatment Reviews. 68. 102–110. 187 indexed citations

14.

Buono, Giuseppe, Francesco Schettini, Francesco Perri, et al.. (2018). The Impact of Translational Research in Breast Cancer Care: Can we Improve the Therapeutic Scenario?. Anti-Cancer Agents in Medicinal Chemistry. 18(6). 832–836. 3 indexed citations

15.

Schettini, Francesco, Giuseppe Buono, Meghana V. Trivedi, et al.. (2017). PI3K/mTOR Inhibitors in the Treatment of Luminal Breast Cancer. Why, When and to Whom. Breast Care. 12(5). 290–294. 16 indexed citations

16.

Buono, Giuseppe, Mario Giuliano, Carmine De Angelis, et al.. (2017). Pretreatment Serum Concentration of Vitamin D and Breast Cancer Characteristics: A Prospective Observational Mediterranean Study. Clinical Breast Cancer. 17(7). 559–563. 12 indexed citations

17.

Crispo, Anna, Maurizio Montella, Giuseppe Buono, et al.. (2016). Body weight and risk of molecular breast cancer subtypes among postmenopausal Mediterranean women. Current Research in Translational Medicine. 64(1). 15–20. 7 indexed citations

18.

Schettini, Francesco, Giuseppe Buono, Cinzia Cardalesi, et al.. (2016). Hormone Receptor/Human Epidermal Growth Factor Receptor 2-positive breast cancer: Where we are now and where we are going. Cancer Treatment Reviews. 46. 20–26. 89 indexed citations

19.

Arpino, Grazia, Carmine De Angelis, Giuseppe Buono, et al.. (2015). Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy. Breast Cancer Research and Treatment. 154(1). 127–132. 36 indexed citations

20.

Price, Gregory D., Richard J. Twitchett, James R. Wheeley, & Giuseppe Buono. (2013). Isotopic evidence for long term warmth in the Mesozoic. Scientific Reports. 3(1). 1438–1438. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact